Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.02), $0.03 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $496.25 million versus the consensus estimate of $534.01 million.

GUIDANCE:

Evolent Health sees FY2026 revenue of $2.4-2.6 billion, versus the consensus of $2.5 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.